Page contentsPage contents Key facts Decision Key facts Active substance testosterone Therapeutic area Ophthalmology Decision number P/0087/2016 PIP number EMEA-001873-PIP01-15 Pharmaceutical form(s) Eye drops, solution Condition(s) / indication(s) Treatment of dry eye disease Route(s) of administration Ocular use Contact for public enquiries AbbVie LtdE-mail: paediatricteam@abbvie.comTel. +44(0) 1628925033 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 18/03/2016 Compliance check done No Decision P/0087/2016: EMA decision of 18 March 2016 on the granting of a product specific waiver for testosterone (EMEA-001873-PIP01-15)Adopted Reference Number: EMA/136748/2016 English (EN) (88.47 KB - PDF)First published: 25/04/2016 Last updated: 25/04/2016 View Share this page